Literature DB >> 19118589

Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.

Maria L H Vlaming1, Jurjen S Lagas, Alfred H Schinkel.   

Abstract

The multidrug transporter ABCG2 (BCRP/MXR/ABCP) can actively extrude a broad range of endogenous and exogenous substrates across biological membranes. ABCG2 limits oral availability and mediates hepatobiliary and renal excretion of its substrates, and thus influences the pharmacokinetics of many drugs. Recent work, relying mainly on the use of Abcg2(-/-) mice, has revealed important contributions of ABCG2 to the blood-brain, blood-testis and blood-fetal barriers. Together, these functions indicate a primary biological role of ABCG2 in protecting the organism from a range of xenobiotics. In addition, several other physiological functions of ABCG2 have been observed, including extrusion of porphyrins and/or porphyrin conjugates from hematopoietic cells, liver and harderian gland, as well as secretion of vitamin B(2) (riboflavin) and possibly other vitamins (biotin, vitamin K) into breast milk. However, the physiological significance of these processes has been difficult to establish, indicating that there is still a lot to learn about this intriguing protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19118589     DOI: 10.1016/j.addr.2008.08.007

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  63 in total

1.  Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice.

Authors:  Sagar Agarwal; Yasuo Uchida; Rajendar K Mittapalli; Ramola Sane; Tetsuya Terasaki; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2012-03-08       Impact factor: 3.922

2.  Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP.

Authors:  Hiroyuki Kusuhara; Hidetoshi Furuie; Akihiro Inano; Akihiro Sunagawa; Saiko Yamada; Chunyong Wu; Shinya Fukizawa; Nozomi Morimoto; Ichiro Ieiri; Mariko Morishita; Kiminobu Sumita; Hiroshi Mayahara; Takuya Fujita; Kazuya Maeda; Yuichi Sugiyama
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

3.  Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier.

Authors:  G Moreno-Sanz; O Sasso; A Guijarro; O Oluyemi; R Bertorelli; A Reggiani; D Piomelli
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1.

Authors:  Takashi Sugiyama; Tsuyoshi Shuto; Shingo Suzuki; Takashi Sato; Tomoaki Koga; Mary Ann Suico; Hiroyuki Kusuhara; Yuichi Sugiyama; Douglas M Cyr; Hirofumi Kai
Journal:  Biochem Biophys Res Commun       Date:  2010-12-22       Impact factor: 3.575

Review 5.  Physiologic and anatomic characterization of the brain surface glia barrier of Drosophila.

Authors:  Michael K DeSalvo; Nasima Mayer; Fahima Mayer; Roland J Bainton
Journal:  Glia       Date:  2011-02-23       Impact factor: 7.452

Review 6.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 7.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 8.  An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.

Authors:  Lyrialle W Han; Chunying Gao; Qingcheng Mao
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-08-03       Impact factor: 4.481

9.  Chalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4.

Authors:  Robert L Myette; Gwenaëlle Conseil; Sean P Ebert; Bryan Wetzel; Michael R Detty; Susan P C Cole
Journal:  Drug Metab Dispos       Date:  2013-03-25       Impact factor: 3.922

10.  Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3).

Authors:  Durga Kalyani Paturi; Deep Kwatra; Hari Krishna Ananthula; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2009-09-25       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.